Company Filing History:
2 out of 1,210 
1 out of 1,386 
Years Active: 2019-2024
Title: The Innovative Contributions of Thanh Barbie
Introduction
Thanh Barbie is a notable inventor based in Andover, MA (US), recognized for his significant contributions to cancer research and treatment. With a focus on innovative methodologies, he has developed patents that aim to enhance cancer immunotherapy and improve patient outcomes.
Latest Patents
Thanh Barbie holds 2 patents that reflect his commitment to advancing cancer treatment. His latest patents include "STING levels as a biomarker for cancer immunotherapy," which provides methods for utilizing Stimulator of Interferon Genes (STING) and Stimulated 3 Prime Antisense Retroviral Coding Sequences (SPARCS) genes as biomarkers to determine effective therapies for cancer treatment. Additionally, he has developed a patent titled "Microfluidic cell culture of patient-derived tumor cell spheroids," which outlines methods for culturing tumor cell spheroids in a three-dimensional microfluidic device. This innovative approach allows for the simultaneous exposure of cultured patient-derived primary tumor cell spheroids to various treatments.
Career Highlights
Throughout his career, Thanh Barbie has worked with esteemed institutions such as Dana-Farber Cancer Institute and Brigham and Women's Hospital. His work in these organizations has contributed to the advancement of cancer research and treatment methodologies.
Collaborations
Thanh Barbie has collaborated with notable colleagues, including David Barbie and Amir Aref, to further enhance the impact of his research and innovations in the field of cancer treatment.
Conclusion
Thanh Barbie's innovative patents and career achievements underscore his dedication to improving cancer therapies. His work continues to influence the landscape of cancer research and treatment methodologies.